课题基金 / 基金详情

The Role of Connexin40 in the Pathogenesis of Atrial Fibrillation Probed by Targeted In Vivo Gene Transfer

The Role of Connexin40 in the Pathogenesis of Atrial Fibrillation Probed by Targeted In Vivo Gene Transfer
通过体内靶向基因转移探讨 Connexin40 在心房颤动发病机制中的作用
批准号:
nhmrc : 503802
负责人:
Dr Eddy Kizana
金额:
$35.27万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2011-12-31

项目摘要

项目成果

Dr Eddy Kizana的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Atrial fibrillation (AF) is a fast and irregular heart rhythm that can predispose sufferers to heart failure and stroke. AF occurs as the result of abnormal electrical conduction in the upper heart chambers. We have found that a protein called Cx40 causes abnormal conduction in heart cells when grown in culture. The aim of this research is to see if AF occurs when Cx40 is increased and prevented when Cx40 is decreased in an AF animal model, potentially defining Cx40 as new therapeutic target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical Assessment of Gene Therapy for Ventricular Arrhythmia
  • 批准号:
    nhmrc : 1128864
  • 项目类别:
    Project Grants
  • 资助金额:
    $54.66万
  • 财政年份:
    2017
  • 负责人:
    Dr Eddy Kizana
  • 依托单位:
A new paradigm in redox-mediated cardiac fibrosis
  • 批准号:
    nhmrc : 1129685
  • 项目类别:
    Project Grants
  • 资助金额:
    $59.22万
  • 财政年份:
    2017
  • 负责人:
    Dr Eddy Kizana
  • 依托单位:
海外基金